Latest Insider Transactions at Amneal Pharmaceuticals, Inc. (AMRX)
This section provides a real-time view of insider transactions for Amneal Pharmaceuticals, Inc. (AMRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Amneal Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Amneal Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2025
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,579
-11.27%
|
$124,632
$8.84 P/Share
|
|
Mar 04
2025
|
Jason B. Daly EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,879
+20.61%
|
-
|
|
Mar 04
2025
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
19,537
-4.5%
|
$156,296
$8.84 P/Share
|
|
Mar 04
2025
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
38,194
+8.08%
|
-
|
|
Mar 04
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,497
-3.02%
|
$179,976
$8.84 P/Share
|
|
Mar 04
2025
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,981
+5.58%
|
-
|
|
Mar 04
2025
|
Chintu Patel Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
46,528
-5.11%
|
$372,224
$8.84 P/Share
|
|
Mar 04
2025
|
Chintu Patel Co-CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
92,592
+9.23%
|
-
|
|
Mar 04
2025
|
Chirag K. Patel President & Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
47,361
-5.23%
|
$378,888
$8.84 P/Share
|
|
Mar 04
2025
|
Chirag K. Patel President & Co-CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
92,592
+9.28%
|
-
|
|
Mar 04
2025
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
18,353
-4.02%
|
$146,824
$8.84 P/Share
|
|
Mar 04
2025
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,879
+7.29%
|
-
|
|
Mar 03
2025
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,145
-24.75%
|
$393,160
$8.76 P/Share
|
|
Mar 03
2025
|
Jason B. Daly EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
151,451
+43.96%
|
-
|
|
Mar 03
2025
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
125,805
-10.19%
|
$1,006,440
$8.76 P/Share
|
|
Mar 03
2025
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
245,950
+16.14%
|
-
|
|
Mar 03
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
133,410
-6.09%
|
$1,067,280
$8.76 P/Share
|
|
Mar 03
2025
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
283,789
+11.31%
|
-
|
|
Mar 03
2025
|
Chintu Patel Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
274,307
-25.11%
|
$2,194,456
$8.76 P/Share
|
|
Mar 03
2025
|
Chintu Patel Co-CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
579,710
+34.67%
|
-
|
|
Mar 03
2025
|
Chirag K. Patel President & Co-CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
279,527
-25.59%
|
$2,236,216
$8.76 P/Share
|
|
Mar 03
2025
|
Chirag K. Patel President & Co-CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
579,710
+34.67%
|
-
|
|
Mar 03
2025
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
116,128
-8.88%
|
$929,024
$8.76 P/Share
|
|
Mar 03
2025
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
227,032
+14.36%
|
-
|
|
Mar 03
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
80,000
-4.24%
|
$640,000
$8.9 P/Share
|
|
Mar 01
2025
|
Andrew S Boyer Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,737
-4.07%
|
$93,896
$8.67 P/Share
|
|
Mar 01
2025
|
Andrew S Boyer Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,371
+9.82%
|
-
|
|
Mar 01
2025
|
Nikita Shah Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,985
-3.43%
|
$87,880
$8.67 P/Share
|
|
Mar 01
2025
|
Nikita Shah Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
28,958
+8.28%
|
-
|
|
Mar 01
2025
|
Tasos Konidaris Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,494
-2.39%
|
$107,952
$8.67 P/Share
|
|
Mar 01
2025
|
Tasos Konidaris Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,197
+6.04%
|
-
|
|
Feb 03
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
80,000
-4.06%
|
$640,000
$8.14 P/Share
|
|
Jan 08
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
62,590
-3.08%
|
$500,720
$8.01 P/Share
|
|
Jan 02
2025
|
Gautam Patel Director |
SELL
Open market or private sale
|
Direct |
17,410
-0.85%
|
$139,280
$8.01 P/Share
|
|
Nov 22
2024
|
John Kiely Director |
SELL
Open market or private sale
|
Direct |
17,058
-6.0%
|
$136,464
$8.38 P/Share
|
|
Nov 22
2024
|
John Kiely Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,506
+9.11%
|
$114,024
$4.76 P/Share
|
|
Nov 22
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
33,229
-38.36%
|
$265,832
$8.34 P/Share
|
|
Nov 21
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
6,771
-7.25%
|
$54,168
$8.41 P/Share
|
|
Nov 21
2024
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,665
-100.0%
|
$109,320
$8.4 P/Share
|
|
Nov 15
2024
|
Jason B. Daly EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
43,657
-76.16%
|
$349,256
$8.61 P/Share
|
|
Aug 15
2024
|
Andrew S Boyer Executive Vice President |
SELL
Open market or private sale
|
Direct |
40,225
-13.55%
|
$281,575
$7.85 P/Share
|
|
Aug 14
2024
|
Nikita Shah Executive Vice President |
SELL
Open market or private sale
|
Direct |
100,000
-25.53%
|
$700,000
$7.75 P/Share
|
|
Aug 14
2024
|
Andrew S Boyer Executive Vice President |
SELL
Open market or private sale
|
Direct |
22,486
-7.04%
|
$157,402
$7.81 P/Share
|
|
May 17
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
23,447
-20.07%
|
$140,682
$6.73 P/Share
|
|
May 16
2024
|
Deborah M. Autor Director |
SELL
Open market or private sale
|
Direct |
14,553
-11.08%
|
$87,318
$6.76 P/Share
|
|
May 10
2024
|
Deborah M. Autor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+36.78%
|
-
|
|
May 10
2024
|
Emily Peterson Alva Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+23.36%
|
-
|
|
May 10
2024
|
Shlomo Yanai Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+23.73%
|
-
|
|
May 10
2024
|
Ted C Nark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+20.27%
|
-
|
|
May 10
2024
|
J Kevin Buchi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,453
+22.58%
|
-
|